Cargando…
Organ donation after controlled circulatory death (Maastricht classification III) following the withdrawal of life-sustaining treatment in Korea: a suggested guideline
The “Act on hospice and palliative care and decisions on life-sustaining treatment for patients at the end of life” was enacted in February 2018 in Korea. Therefore, we suggest a Korean guideline for organ donation after circulatory death (DCD) category III after the withdrawal of life-sustaining tr...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society for Transplantation
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9235338/ https://www.ncbi.nlm.nih.gov/pubmed/35769520 http://dx.doi.org/10.4285/kjt.21.0004 |
_version_ | 1784736294339870720 |
---|---|
author | Park, Hoonsung Jung, Eun-Sil Oh, Jae-Sook Lee, Yong-Min Lee, Jae-Myeong |
author_facet | Park, Hoonsung Jung, Eun-Sil Oh, Jae-Sook Lee, Yong-Min Lee, Jae-Myeong |
author_sort | Park, Hoonsung |
collection | PubMed |
description | The “Act on hospice and palliative care and decisions on life-sustaining treatment for patients at the end of life” was enacted in February 2018 in Korea. Therefore, we suggest a Korean guideline for organ donation after circulatory death (DCD) category III after the withdrawal of life-sustaining treatment (WLST). Implementation of WLST includes stopping ventilation, extubation, discontinuation of inotropics and vasoconstrictors, cessation of continuous renal replacement therapy, and cessation of extracorporeal membrane oxygenation. Medical staff involved in organ procurement or transplantation surgery cannot participate in the WLST process. Following cardiac arrest, 5 minutes of “no touch time” should pass, after which circulatory death can be declared. The procurement team can enter the room after the declaration of death. The final procurement decision is made after the surgeon visually checks the organ condition. DCD category III activation in Korea will help increase organ donation and reduce the demand-supply mismatch of organ transplantation. |
format | Online Article Text |
id | pubmed-9235338 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | The Korean Society for Transplantation |
record_format | MEDLINE/PubMed |
spelling | pubmed-92353382022-06-28 Organ donation after controlled circulatory death (Maastricht classification III) following the withdrawal of life-sustaining treatment in Korea: a suggested guideline Park, Hoonsung Jung, Eun-Sil Oh, Jae-Sook Lee, Yong-Min Lee, Jae-Myeong Korean J Transplant Review Article The “Act on hospice and palliative care and decisions on life-sustaining treatment for patients at the end of life” was enacted in February 2018 in Korea. Therefore, we suggest a Korean guideline for organ donation after circulatory death (DCD) category III after the withdrawal of life-sustaining treatment (WLST). Implementation of WLST includes stopping ventilation, extubation, discontinuation of inotropics and vasoconstrictors, cessation of continuous renal replacement therapy, and cessation of extracorporeal membrane oxygenation. Medical staff involved in organ procurement or transplantation surgery cannot participate in the WLST process. Following cardiac arrest, 5 minutes of “no touch time” should pass, after which circulatory death can be declared. The procurement team can enter the room after the declaration of death. The final procurement decision is made after the surgeon visually checks the organ condition. DCD category III activation in Korea will help increase organ donation and reduce the demand-supply mismatch of organ transplantation. The Korean Society for Transplantation 2021-06-30 2021-06-30 /pmc/articles/PMC9235338/ /pubmed/35769520 http://dx.doi.org/10.4285/kjt.21.0004 Text en Copyright © 2021 The Korean Society for Transplantation https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Park, Hoonsung Jung, Eun-Sil Oh, Jae-Sook Lee, Yong-Min Lee, Jae-Myeong Organ donation after controlled circulatory death (Maastricht classification III) following the withdrawal of life-sustaining treatment in Korea: a suggested guideline |
title | Organ donation after controlled circulatory death (Maastricht classification III) following the withdrawal of life-sustaining treatment in Korea: a suggested guideline |
title_full | Organ donation after controlled circulatory death (Maastricht classification III) following the withdrawal of life-sustaining treatment in Korea: a suggested guideline |
title_fullStr | Organ donation after controlled circulatory death (Maastricht classification III) following the withdrawal of life-sustaining treatment in Korea: a suggested guideline |
title_full_unstemmed | Organ donation after controlled circulatory death (Maastricht classification III) following the withdrawal of life-sustaining treatment in Korea: a suggested guideline |
title_short | Organ donation after controlled circulatory death (Maastricht classification III) following the withdrawal of life-sustaining treatment in Korea: a suggested guideline |
title_sort | organ donation after controlled circulatory death (maastricht classification iii) following the withdrawal of life-sustaining treatment in korea: a suggested guideline |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9235338/ https://www.ncbi.nlm.nih.gov/pubmed/35769520 http://dx.doi.org/10.4285/kjt.21.0004 |
work_keys_str_mv | AT parkhoonsung organdonationaftercontrolledcirculatorydeathmaastrichtclassificationiiifollowingthewithdrawaloflifesustainingtreatmentinkoreaasuggestedguideline AT jungeunsil organdonationaftercontrolledcirculatorydeathmaastrichtclassificationiiifollowingthewithdrawaloflifesustainingtreatmentinkoreaasuggestedguideline AT ohjaesook organdonationaftercontrolledcirculatorydeathmaastrichtclassificationiiifollowingthewithdrawaloflifesustainingtreatmentinkoreaasuggestedguideline AT leeyongmin organdonationaftercontrolledcirculatorydeathmaastrichtclassificationiiifollowingthewithdrawaloflifesustainingtreatmentinkoreaasuggestedguideline AT leejaemyeong organdonationaftercontrolledcirculatorydeathmaastrichtclassificationiiifollowingthewithdrawaloflifesustainingtreatmentinkoreaasuggestedguideline |